Cyclacel Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Cyclacel Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update

Cyclacel Pharma (CYCC) Tops Q3 EPS by 18c

November 10, 2021 4:47 PM EST

Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.47), $0.18 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

... More